Compare RMI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMI | OKYO |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.9M | 81.3M |
| IPO Year | 2018 | 2021 |
| Metric | RMI | OKYO |
|---|---|---|
| Price | $15.65 | $1.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 11.3K | ★ 67.6K |
| Earning Date | 01-01-0001 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.71 | $1.42 |
| 52 Week High | $16.36 | $3.35 |
| Indicator | RMI | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 65.73 | 50.07 |
| Support Level | $14.88 | $1.47 |
| Resistance Level | $15.89 | $1.72 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 78.09 | 65.22 |
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.